Rapid Novor Inc
9.8/10 Overall Rating
No Reviews Yet
31 Orders Completed
Waterloo, Ontario, CA
Rapid Novor Inc. is the world's leader in antibody protein sequencing. Specializing in the field of mass spectrometry-based proteomics, the team has developed the technology to directly sequence antibody proteins without needing to access the cell line. As a University of Waterloo spin-off, the company is building its technologies based on the twenty years of scientific research from Dr. Bin Ma, co-founder and chief scientist. The company's REmAb™ service has allowed for the accurate sequencing of any given antibody proteins on a routine basis. The company's WILD™ service is the first commercially available service that can accurately distinguish Isoleucine and Leucine using mass spectrometry.
| Pricing | REmAb™ with WILD™ | REmAb™ Expedite |
|---|---|---|
| Price per mAb | US$12,999 (US$4,999 ***) | Add US$2,000 |
| Ile/Leu calls | Determined by w-ion | |
| Turnaround | 2 weeks | 1 week |
| Report | HC and LC full sequences | HC and LC full sequences |
*** For a LIMITED TIME only, introductory discount to new customers in the first order.
| Pricing | REmAb™ with WILD™ | REmAb™ Expedite |
|---|---|---|
| Price per mAb | US$12,999 (US$4,999 ***) | Add US$2,000 |
| Ile/Leu calls | Determined by w-ion | |
| Turnaround | 2 weeks | 1 week |
| Report | HC and LC full sequences | HC and LC full sequences |
*** For a LIMITED TIME only, introductory discount to new customers in the first order.
You provide: Monoclonal antibody sample (>0.2mg, >95% purity, >0.5mg/mL concentration, without excessive BSA or other proteins)
We deliver: Full sequence of heavy and light chains; Full sequence coverage by LC-MS/MS; Comprehensive report.
Money-back guarantee – We guarantee at least 5X coverage of the CDRs, 3X coverage for 95% of the sequence, and 1X coverage for the full length. If the target coverage is not met, you will be fully refunded.
Rapid Novor offers antibody de novo sequencing service. We directly sequence the antibody protein using multiple enzyme digestion and high resolution LC-MS/MS. Our service guarantees full length sequencing of the heavy and light chains.
Our sequencing process does not require hybridoma, mRNA, or other sequence information. It provides a direct and independent insight into your antibody sample.
Accurate – We guarantee at least 5X coverage of CDRs in the variable regions. Every amino acid in the CDRs is confidently supported by fragment ions in at least five MS2 scans. For isomeric Leu and Ile, we strive to make correct inference from enzyme specificity and statistics in antibody database.
Comprehensive – As an option, we offer comprehensive characterization of the antibody protein. Our service includes the analyses of PTMs, glycosylation, disulphide bridges, contaminants, and other aspects customized to your needs.
Efficient – We use minimal amount of antibody sample (0.1 mg) and deliver results within 2 weeks with consistent quality.
Our team specializes in protein mass spectrometry and informatics. We develop proprietary workflow and software for antibody de novo sequencing. Our standard procedure consists of the following steps.
| Pricing | REmAb™ with WILD™ | REmAb™ Expedite |
|---|---|---|
| Price per mAb | US$12,999 (US$4,999 ***) | Add US$2,000 |
| Ile/Leu calls | Determined by w-ion | |
| Turnaround | 2 weeks | 1 week |
| Report | Heavy and light chain full sequences | Heavy and light chain full sequences |
*** For a LIMITED TIME only, introductory discount to new customers in the first order.
You provide: Monoclonal antibody sample (>0.2mg, >95% purity, >0.5mg/mL concentration, without excessive BSA or other proteins)
We deliver: Full sequence of heavy and light chains; Full sequence coverage by LC-MS/MS; Comprehensive report.
Money-back guarantee – We guarantee at least 5X coverage of the CDRs, 3X coverage for 95% of the sequence, and 1X coverage for the full length. If the target coverage is not met, you will be fully refunded.
Rapid Novor offers antibody de novo sequencing service. We directly sequence the antibody protein using multiple enzyme digestion and high resolution LC-MS/MS. Our service guarantees full length sequencing of the heavy and light chains.
Our sequencing process does not require hybridoma, mRNA, or other sequence information. It provides a direct and independent insight into your antibody sample.
Accurate – We guarantee at least 5X coverage of CDRs in the variable regions. Every amino acid in the CDRs is confidently supported by fragment ions in at least five MS2 scans. For isomeric Leu and Ile, we strive to make correct inference from enzyme specificity and statistics in antibody database.
Comprehensive – As an option, we offer comprehensive characterization of the antibody protein. Our service includes the analyses of PTMs, glycosylation, disulphide bridges, contaminants, and other aspects customized to your needs.
Efficient – We use minimal amount of antibody sample (0.2 mg) and deliver results within 15 business days with consistent quality.
Our team specializes in protein mass spectrometry and informatics. We develop proprietary workflow and software for antibody de novo sequencing. Our standard procedure consists of the following steps.
| Pricing | REmAb™ with WILD™ | REmAb™ Expedite |
|---|---|---|
| Price per mAb | US$12,999 (US$4,999 ***) | Add US$2,000 |
| Ile/Leu calls | Determined by w-ion | |
| Turnaround | 2 weeks | 1 week |
| Report | Heavy and light chain full sequences | Heavy and light chain full sequences |
*** For a LIMITED TIME only, introductory discount to new customers in the first order.
You provide: Monoclonal antibody sample (>0.2mg, >95% purity, >0.5mg/mL concentration, without excessive BSA or other proteins)
We deliver: Full sequence of heavy and light chains; Full sequence coverage by LC-MS/MS; Comprehensive report.
Money-back guarantee – We guarantee at least 5X coverage of the CDRs, 3X coverage for 95% of the sequence, and 1X coverage for the full length. If the target coverage is not met, you will be fully refunded.
Rapid Novor offers antibody de novo sequencing service. We directly sequence the antibody protein using multiple enzyme digestion and high resolution LC-MS/MS. Our service guarantees full length sequencing of the heavy and light chains.
Our sequencing process does not require hybridoma, mRNA, or other sequence information. It provides a direct and independent insight into your antibody sample.
Accurate – We guarantee at least 5X coverage of CDRs in the variable regions. Every amino acid in the CDRs is confidently supported by fragment ions in at least five MS2 scans. For isomeric Leu and Ile, we strive to make correct inference from enzyme specificity and statistics in antibody database.
Comprehensive – As an option, we offer comprehensive characterization of the antibody protein. Our service includes the analyses of PTMs, glycosylation, disulphide bridges, contaminants, and other aspects customized to your needs.
Efficient – We use minimal amount of antibody sample (0.2 mg) and deliver results within 15 business days with consistent quality.
Our team specializes in protein mass spectrometry and informatics. We develop proprietary workflow and software for antibody de novo sequencing. Our standard procedure consists of the following steps.
You provide: Monoclonal antibody sample (>0.2mg, >95% purity, >0.5mg/mL concentration, without excessive BSA or other proteins)
We deliver: 3 mg purified antibody in IgG format; QC data; Full sequence of heavy and light chains; Comprehensive sequencing report.
Money-back guarantee – We guarantee that the antibody we produced binds to the same antigen with similar affinity as the antibody sample provided.
Rapid Novor offers the "Sequencing + Expression" service to deliver antibodies that works. We directly sequence the antibody protein and then make a recombinant version of it. Our service guarantees that the antibody we produced binds to the same antigen with similar affinity as the antibody sample provided.
The standard "Sequencing + Expression" service consists of the following steps:
You provide: Monoclonal antibody sample (>0.2mg, >95% purity, >0.5mg/mL concentration, without excessive BSA or other proteins)
We deliver: Full sequence of heavy and light chains; Full sequence coverage by LC-MS/MS; Comprehensive report; PTM and Glycosylation report (optional) and Raw LC-MS/MS data.
Money-back guarantee – We guarantee at least 5X coverage of the CDRs, 3X coverage for 95% of the sequence, and 1X coverage for the full length. If the target coverage is not met, you will be fully refunded.
Promotion - We will sequence the first antibody protein for new customers at half of our regular price!
Rapid Novor offers antibody de novo sequencing service. We directly sequence the antibody protein using multiple enzyme digestion and high resolution LC-MS/MS. Our service guarantees full length sequencing of the heavy and light chains.
Our sequencing process does not require hybridoma, mRNA, or other sequence information. It provides a direct and independent insight into your antibody sample.
Accurate – We guarantee at least 5X coverage of CDRs in the variable regions. Every amino acid in the CDRs is confidently supported by fragment ions in at least five MS2 scans. For isomeric Leu and Ile, we strive to make correct inference from enzyme specificity and statistics in antibody database.
Comprehensive – As an option, we offer comprehensive characterization of the antibody protein. Our service includes the analyses of PTMs, glycosylation, disulphide bridges, contaminants, and other aspects customized to your needs.
Efficient – We use minimal amount of antibody sample (0.2 mg) and deliver results within 15 business days with consistent quality.
Our team specializes in protein mass spectrometry and informatics. We develop proprietary workflow and software for antibody de novo sequencing. Our standard procedure consists of the following steps.
Protein Characterization Services
Rapid Novor Inc has not received any reviews.
Rapid Novor Inc has not received any endorsements.